A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Cirrhosis

Interventions

DRUG

OPC-41061

OPC-41061 tablets will be orally administered once daily after breakfast at 7.5 mg on Day 1 to 7 and at either 7.5 or 15 mg on Day 8 to 14.

Trial Locations (6)

Chubu Region

Chugoku Region

Kanto Region

Kinki Region

Kyushu Region

Tohoku Region